Teoxane consent form: Free PDF download & guide

Key Takeaways

A teoxane consent form documents patient understanding of Teoxane (Teosyal) hyaluronic acid dermal filler procedures before treatment begins.

UK-based aesthetic practitioners must obtain written informed consent that complies with GDPR, JCCP standards, and Save Face guidelines; US practitioners follow FDA and HIPAA requirements.

Essential consent form sections include contraindication screening, risk disclosure (vascular occlusion, allergic reaction, bruising), pre/post-care instructions, and signature fields for both patient and practitioner.

Pabau’s digital forms feature streamlines consent collection via patient portals, automating workflows while maintaining compliance documentation for audit and regulatory review.

Aesthetic practitioners who administer Teoxane (Teosyal) dermal fillers face a critical compliance requirement: obtaining informed consent from patients before treatment. A professional teoxane consent form protects both the patient and your practice by documenting that the patient understands the procedure, potential risks, contraindications, and aftercare obligations.

This article covers what a clinic-ready teoxane consent form must include, how to use it in your workflow, and why this template matters for aesthetic practice compliance.

What is a teoxane consent form?

A teoxane consent form is a legal medical document that confirms a patient has been informed about a Teoxane dermal filler treatment and agrees to proceed with it. Teoxane Laboratories, founded in 2003 and based in Geneva, manufactures Teosyal-a hyaluronic acid-based filler used for lip augmentation, nasolabial fold treatment, cheek enhancement, and anti-wrinkle correction.

The consent form captures patient acknowledgment of the treatment’s benefits, potential side effects, absolute and relative contraindications, and post-treatment care requirements.

In the UK, informed consent is a legal and ethical requirement governed by GDPR (data protection), MHRA guidance (medicines safety), and professional standards set by the Joint Council for Cosmetic Practitioners (JCCP) and Save Face accreditation. In the US, the FDA and HIPAA establish similar requirements. Without documented consent, aesthetic practitioners expose their clinics to regulatory findings, complaints, and litigation.

What to include in a teoxane consent form

A clinic-ready teoxane consent form must cover specific sections to satisfy regulatory bodies and protect your practice. Here are the essential elements:

• Patient identification – full name, date of birth, contact details, and clinic ID (ensures the right patient is consenting)
• Treatment description – what Teoxane product is being used, treatment site, and expected duration of results
• Contraindications screening – two-tier structure: absolute contraindications (pregnancy, breastfeeding, active infections, bleeding disorders) and relative contraindications (certain medications, allergies, previous severe reactions)
• Risk disclosure – common side effects (bruising, swelling, tenderness) and serious rare risks (vascular occlusion, allergic reaction, anaphylaxis, granuloma formation)
• Pre-treatment instructions – avoid blood thinners, alcohol, and strenuous exercise 24 hours before; disclose all medications and supplements
• Post-treatment care – avoid facial massage, extreme heat, sun exposure, and strenuous activity for 24-48 hours; expected results timeline (3-7 days for full effect)
• Practitioner qualifications statement – confirmation that the injector holds relevant qualifications (NP, PA, RN with aesthetic training, or physician)
• Patient acknowledgment – signature line confirming the patient understands risks and consents freely
• Practitioner signature – the administering clinician signs to confirm consent was explained and obtained
• Date and witness line (optional) – some clinics have a third party (staff member or family member) witness signatures for additional protection

The form must be written in plain language, avoiding medical jargon where possible. A teoxane consent form that uses overly technical language fails the regulatory test: patients must genuinely understand what they’re consenting to, not just sign a document they don’t comprehend.

How to use a teoxane consent form in your clinic

Integrating a teoxane consent form into your clinic workflow requires five key steps:

1. Pre-consultation – Email or hand the patient the form before their appointment so they can review it at home. Answer any questions during the consultation phase, before any treatment is booked.
2. Consultation meeting – Review the form face-to-face with the patient. Discuss their medical history, contraindications, and any previous filler reactions. Document any deviations from standard aftercare (e.g., if they have a scheduled event within 48 hours).
3. Patient confirmation – Have the patient read and sign the form at least 24 hours before treatment (best practice; check your insurance policy for minimum waiting periods). Do not accept verbal consent alone.
4. Digital storage – Scan or store the signed form in your clinic management system with secure, encrypted access. Digital forms software automates this: patients complete consent via a secure portal, timestamps are recorded, and the form is encrypted in the patient’s record for audit and compliance review.
5. Retention protocol – Keep signed teoxane consent forms for a minimum of 6 years (UK GDPR retention period for healthcare records) or 7 years (US HIPAA standard). Establish a destruction policy once the retention period expires.

Clinics using aesthetic clinic management software can streamline this workflow: patients complete the consent form via a secure patient portal before their appointment, the form is automatically stored in the patient record with a timestamp, and the clinic team receives an alert confirming completion. This reduces administrative burden and ensures no appointment proceeds without documented consent.

Regulatory compliance context for teoxane treatments

In the UK, aesthetic practitioners administering dermal fillers must comply with MHRA guidance on medical devices (Teoxane products are CE-marked medical devices) and follow professional standards from the Joint Council for Cosmetic Practitioners.

In the US, the FDA regulates hyaluronic acid dermal fillers as medical devices. Practitioners must obtain informed consent that addresses FDA-recognized risks. HIPAA requires that consent documentation be stored with access controls and breach notification procedures in place.

Many US states require injectors to hold a nursing license, physician credential, or licensed aesthetician status with specific injectable training certification; the consent form should reference the injector’s credential.

Common mistakes in teoxane consent forms

Several consent form pitfalls undermine compliance:

• Generic filler language – a teoxane consent form that copies generic “dermal filler” language without mentioning Teoxane products by name fails to address product-specific risks. Always name the product.
• Incomplete contraindication screening – forms that miss relative contraindications (e.g., patients on anticoagulants, history of keloid formation, recent skin procedures) leave you exposed. Include a detailed medical history questionnaire.
• Missing signature date – unsigned or undated consent forms are treated as invalid in audit. Both patient and practitioner signatures must include the date.
• Unclear aftercare – vague post-treatment guidance (e.g., “avoid strenuous activity”) lacks specificity. State “avoid strenuous activity for 48 hours” or reference a separate aftercare handout.
• No record of explanation – consent forms should include a practitioner checkbox confirming “I have discussed the above risks and benefits with this patient in person and answered their questions.” This documents that consent was informed, not just read and signed.

Professional consultations paired with structured consent workflows reduce these errors and establish a strong clinical record.

Why a digital consent form matters

Paper consent forms work, but digital teoxane consent forms offer compliance advantages. When patients complete consent via a secure portal, the system records the timestamp, IP address, and patient confirmation. This creates an auditable trail: regulators can see exactly when and where the patient consented.

AI-assisted clinical documentation can also help practices draft follow-up notes that cross-reference the consent form, ensuring continuity between what the patient agreed to and what the practitioner recorded in the clinical note.

Digital forms also reduce errors: if a patient skips a section (e.g., doesn’t tick the contraindication screening boxes), the form prompts them to complete it before submission. This prevents incomplete consent documentation from entering your system.

Ready to streamline your teoxane consent workflow? Book a demo with Pabau to see how digital forms integrate with your patient portal, appointment booking, and clinical records in a single platform.

Aftercare guidance linked to teoxane

The teoxane consent form is the starting point; aftercare guidance is the follow-through. Many clinics pair the consent document with a separate aftercare handout or automated SMS reminders. Patients who receive structured post-treatment instructions (avoid facial massage for 24 hours, no extreme heat for 48 hours, ice as needed for swelling, avoid blood thinners) report fewer adverse reactions and higher satisfaction.

Aesthetic EMR software with automated aftercare messaging sends these instructions automatically after each appointment, ensuring consistency and reducing practitioner workload.

Documenting that the patient received and acknowledged aftercare instructions strengthens your compliance record. A teoxane consent form should reference where aftercare details are provided (printed handout, patient portal, SMS reminder) so the regulatory trail is complete.

Conclusion

A professional teoxane consent form is the foundation of safe, legally defensible aesthetic practice. By obtaining informed, written consent that addresses Teoxane-specific risks, contraindications, and aftercare, you protect both your patients and your clinic.

The template provided above includes all essential sections-use it as a starting point, customise it to your practice jurisdiction and specific Teoxane products, and ensure your team reviews it with every patient before treatment.

Clinics that treat consent as a clinical conversation, not just paperwork, build trust and reduce complaints. Ready to automate your consent workflow and free up clinical time? Explore Pabau’s digital forms and how they integrate with your patient records to streamline compliance from first consultation to follow-up.

Frequently asked questions